Amgen, Inc. (AMGN)
382.43
-8.84
(-2.26%)
USD |
NASDAQ |
Sep 10, 16:00
383.38
+0.95
(+0.25%)
After-Hours: 18:10
Amgen Total Long Term Debt (Quarterly) : 57.30B for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 57.30B |
| March 31, 2026 | 57.32B |
| December 31, 2025 | 55.30B |
| September 30, 2025 | 54.59B |
| June 30, 2025 | 56.20B |
| March 31, 2025 | 57.38B |
| December 31, 2024 | 60.77B |
| September 30, 2024 | 60.40B |
| June 30, 2024 | 62.64B |
| March 31, 2024 | 64.02B |
| December 31, 2023 | 65.30B |
| September 30, 2023 | 60.47B |
| June 30, 2023 | 61.54B |
| March 31, 2023 | 61.60B |
| December 31, 2022 | 39.48B |
| September 30, 2022 | 38.70B |
| June 30, 2022 | 36.52B |
| March 31, 2022 | 36.85B |
| December 31, 2021 | 33.83B |
| September 30, 2021 | 37.58B |
| June 30, 2021 | 32.78B |
| March 31, 2021 | 32.68B |
| December 31, 2020 | 33.29B |
| September 30, 2020 | 34.29B |
| June 30, 2020 | 34.22B |
| Date | Value |
|---|---|
| March 31, 2020 | 31.85B |
| December 31, 2019 | 30.29B |
| September 30, 2019 | 30.14B |
| June 30, 2019 | 30.98B |
| March 31, 2019 | 33.39B |
| December 31, 2018 | 33.93B |
| September 30, 2018 | 34.43B |
| June 30, 2018 | 34.50B |
| March 31, 2018 | 35.54B |
| December 31, 2017 | 35.34B |
| September 30, 2017 | 35.78B |
| June 30, 2017 | 35.06B |
| March 31, 2017 | 34.09B |
| December 31, 2016 | 33.99B |
| September 30, 2016 | 35.32B |
| June 30, 2016 | 33.22B |
| March 31, 2016 | 34.31B |
| December 31, 2015 | 31.56B |
| September 30, 2015 | 31.76B |
| June 30, 2015 | 31.95B |
| March 31, 2015 | 30.34B |
| December 31, 2014 | 30.72B |
| September 30, 2014 | 32.98B |
| June 30, 2014 | 33.33B |
| March 31, 2014 | 32.02B |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 26.25B |
| Regeneron Pharmaceuticals, Inc. | 2.707B |
| AbbVie, Inc. | 70.82B |
| Biogen, Inc. | 8.355B |
| Vertex Pharmaceuticals, Inc. | 1.978B |